http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Princeton, NJ and San Diego, CA, November 12, 2009--Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening... http://pharmalicensing.com/redirs/news_rss//public/news/view/499708/0/8/tobira-therapeutics-inc-announce-presentation-of-tbr-652-data-at-european-aids-conference http://pharmalicensing.com/redirs/news_rss//public/news/view/499708/0/8/tobira-therapeutics-inc-announce-presentation-of-tbr-652-data-at-european-aids-conference Montr http://pharmalicensing.com/redirs/news_rss//public/news/view/499756/0/8/theratechnologies-presents-combined-phase-3-clinical-results-at-european-aids-conference http://pharmalicensing.com/redirs/news_rss//public/news/view/499756/0/8/theratechnologies-presents-combined-phase-3-clinical-results-at-european-aids-conference November 11, 2009--A recent paper, by researchers at Genentech, describes the preclinical evaluation of the pharmacokinetic properties of GDC-0449, a potent selective Hedgehog signalling pathway... http://pharmalicensing.com/redirs/news_rss//public/news/view/499713/0/8/simcyp-simulator-aids-in-preclinical-adme-assessment-of-genentech-compound http://pharmalicensing.com/redirs/news_rss//public/news/view/499713/0/8/simcyp-simulator-aids-in-preclinical-adme-assessment-of-genentech-compound ROCKVILLE, MD (November 11, 2009) - Novavax, Inc. (NASDAQ: NVAX) a clinical-stage vaccine company, announced today that John Trizzino, Senior Vice President, International and Government Alliances,... http://pharmalicensing.com/redirs/news_rss//public/news/view/499714/0/8/novavax-to-present-at-the-influenza-congress-usa-2009 http://pharmalicensing.com/redirs/news_rss//public/news/view/499714/0/8/novavax-to-present-at-the-influenza-congress-usa-2009 Birmingham, United Kingdom, November 11, 2009 - Finnish molecular diagnostics company Mobidiag releases rapid microarray solution for identifying bacteria responsible for bone and joint infections... http://pharmalicensing.com/redirs/news_rss//public/news/view/499724/0/8/mobidiag-launches-rapid-dna-microarray-technology-for-diagnostics-of-bone-and-joint-infections http://pharmalicensing.com/redirs/news_rss//public/news/view/499724/0/8/mobidiag-launches-rapid-dna-microarray-technology-for-diagnostics-of-bone-and-joint-infections 10 November 2009, London UK & Philadelphia US -- GlaxoSmithKline (GSK) today announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA)... http://pharmalicensing.com/redirs/news_rss//public/news/view/499780/0/8/pandemic-2009-influenza-update-us-fda-approves-gsks-pandemic-h1n1-vaccine http://pharmalicensing.com/redirs/news_rss//public/news/view/499780/0/8/pandemic-2009-influenza-update-us-fda-approves-gsks-pandemic-h1n1-vaccine CHICAGO, Nov. 10-- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the... http://pharmalicensing.com/redirs/news_rss//public/news/view/499668/0/8/advanced-life-sciences-announces-third-quarter-2009-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499668/0/8/advanced-life-sciences-announces-third-quarter-2009-financial-results Tuesday 10 November 2009, London, UK -- GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted... http://pharmalicensing.com/redirs/news_rss//public/news/view/499627/0/8/gsk-signs-agreement-with-the-who-to-donate-50-million-doses-of-pandemic-h1n1-vaccine-for-distribution-to-developing-countries http://pharmalicensing.com/redirs/news_rss//public/news/view/499627/0/8/gsk-signs-agreement-with-the-who-to-donate-50-million-doses-of-pandemic-h1n1-vaccine-for-distribution-to-developing-countries Rehovot (Israel), November 4, 2009 -- Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration... http://pharmalicensing.com/redirs/news_rss//public/news/view/498855/0/8/foamix-expands-international-patent-protection-for-its-emollient-foam-platform http://pharmalicensing.com/redirs/news_rss//public/news/view/498855/0/8/foamix-expands-international-patent-protection-for-its-emollient-foam-platform LEXINGTON, MA - November 4, 2009 - Antigenics, Inc. (NASDAQ: AGEN) today indicated that GlaxoSmithKline's (GSK) Phase III malaria vaccine clinical trial, containing Antigenics' QS-21 Stimulon http://pharmalicensing.com/redirs/news_rss//public/news/view/498862/0/8/antigenics-provides-details-on-glaxosmithklines-pivotal-malaria-vaccine-trial-with-qs-21-adjuvant http://pharmalicensing.com/redirs/news_rss//public/news/view/498862/0/8/antigenics-provides-details-on-glaxosmithklines-pivotal-malaria-vaccine-trial-with-qs-21-adjuvant